Risk Factors for PONV in Patients Undergoing Hysteroscopic Surgery

Completed

• Conditions: Gynecologic Nursing; Postoperative Complications
• Interventions: Other: Non-existence of nausea and vomiting within 24 hours after surgery; Other: The presence of nausea and vomiting within 24 hours after surgery

• Registration Number: NCT06524752
• Lead Sponsor: Weifang Medical University

Brief Summary

The purpose of this study was to construct and validate a risk prediction model for PONV in patients undergoing hysteroscopic day-case surgery.

Detailed Description

This study predicted the risk of postoperative nausea and vomiting in patients undergoing day-case hysteroscopic surgery by constructing and validating a web-based dynamic nomogram.

Study Timeline

• Study Start: 2021-01-01
• Primary Completion: 2024-01-01
• Study Completion: 2024-06-01
• Status Verified: 2024-07
• Study First Submitted: 2024-07-22
• Study First Submitted QC: 2024-07-26
• Last Update Submitted: 2024-07-26
• Study First Posted: 2024-07-29
• Last Update Posted: 2024-07-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 1583

Inclusion Criteria

• Female patients undergoing hysteroscopic day-case surgery and aged 18 years.

Exclusion Criteria

• Patients with intraoperative change of surgical method and unstable postoperative vital signs.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Control group	Non-existence of nausea and vomiting within 24 hours after surgery	The patient did not experience postoperative nausea or vomiting
Observation group	The presence of nausea and vomiting within 24 hours after surgery	The patient experience the postoperative nausea or vomiting

Primary Outcome Measures

Name	Time	Method
PONV	Within 24 hours after surgery	The occurrence and severity of PONV is evaluated by Visual Analogue Scale (VAS). The VAS scale ranges from 0 to 10, with larger scores meaning that the patient has more severe PONV.

Trial Locations

Locations (1)

Weifang People's Hospital; 🇨🇳 Weifang, Shandong, China